Physicochemical Properties
| Molecular Formula | C24H17F3N4O3 |
| Molecular Weight | 466.41 |
| CAS # | 3026111-73-6 |
| PubChem CID | 166176996 |
| Appearance | White to off-white solid powder |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 5 |
| Heavy Atom Count | 34 |
| Complexity | 731 |
| Defined Atom Stereocenter Count | 0 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | TrkA 22.4 nM (IC50) |
| ln Vitro | Compound 5 (TrkA-IN-3) showed 73.9% and 64.8% inhibitory rates against TrkA at 1 μM and 0.1 μM, respectively [1]. |
| References |
[1]. Design, development and evaluation of a prodrug-type TrkA-selective inhibitor with antinociceptive effects in vivo. Eur J Med Chem. 2023 Jan 5;245(Pt 2):114901. |
Solubility Data
| Solubility (In Vitro) | DMSO :~50 mg/mL (~107.20 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (5.36 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.1440 mL | 10.7202 mL | 21.4404 mL | |
| 5 mM | 0.4288 mL | 2.1440 mL | 4.2881 mL | |
| 10 mM | 0.2144 mL | 1.0720 mL | 2.1440 mL |